Patents by Inventor Brian Schutte

Brian Schutte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070009992
    Abstract: The invention provides methods to identify polymorphisms at the human TLR4 locus, as well as methods to identify individuals at risk of indications that increase their morbidity and mortality.
    Type: Application
    Filed: September 7, 2006
    Publication date: January 11, 2007
    Inventors: David Schwartz, Brian Schutte
  • Publication number: 20050277176
    Abstract: The present invention employs an iterative application of BLAST and Hidden Markov Model (HMM) based searches which identified 34 ?-defensin genes in the human genome and 48 in the mouse genome. The present invention relates to novel antimicrobial peptides and derivatives thereof as well as the ?-defensin genes encoding the peptides. The invention further relates to methods of use of the peptides including a method of inhibiting microbial growth by administering an effective amount of the peptide alone or in combination with other antimicrobial agents or antibiotics.
    Type: Application
    Filed: May 3, 2005
    Publication date: December 15, 2005
    Inventors: Paul McCray, Brian Schutte, Hong Jia, Thomas Casavant, Michael Welsh
  • Publication number: 20050192221
    Abstract: The present invention concerns compositions and methods related to the use of peptides and polypeptides corresponding to all or part of the SPLUNC1 and LPLUNC1 proteins. Particular aspects of the invnetion include the use of SPLUNC1 and LPLUNC1 peptides and polypeptides as antimicrobials, anti-inflammatory, and immune modulatory agents.
    Type: Application
    Filed: December 3, 2004
    Publication date: September 1, 2005
    Inventors: Paul McCray, Jerry Weiss, Hong Jia, Brian Schutte, Jennifer Bartlett
  • Publication number: 20050089885
    Abstract: This invention relates to polymorphisms in the IRF6 gene which are associated with various diseases, such as Van der Woude syndrome, Poplitieal syndrome, isolated cleft lip and/or palate, and other orofusial clefting disorders. The invention also relates to the nucleotide sequences of this gene, isolated nucleic acids comprising these nucleotide sequences, and isolated polypeptides or peptides encoded thereby. The invention further relates to vectors and host cells comprising the disclosed nucleotide sequences, or fragments thereof, as well as antibodies that bind to the encoded polypeptides or peptides. In addition the invention relates to methods and compositions employing the disclosed nucleic acids, polypeptides or peptides, or antibodies for use in diagnostics and therapeutics for IRF6 associated disorders, e.g., Van der Woude syndrome, Poplitieal syndrome, isolated cleft lip and/or palate, and other orofusial clefting disorders.
    Type: Application
    Filed: May 6, 2004
    Publication date: April 28, 2005
    Applicant: University of Iowa Research Foundation
    Inventors: Brian Schutte, Jeffrey Murray, Shinji Kondo, Michael Dixon